Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

Roche

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.

Roche

Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA

Roche’s Herceptin/Perjeta fixed-dose combo filed with FDA

Final decision due by 18 October. A fixed-dose combination of Roche’s HER2 drugs Herceptin and Perjeta has started a review at the FDA, with a decision due by 18 ... October. The co-formulation of two of Roche’s blockbuster breast cancer antibodies

Coronavirus outbreak escalation could impact drug supply chain

Coronavirus outbreak escalation could impact drug supply chain Other drug makers, including Roche, Merck &Co, Bayer, Johnson &Johnson and Pfizer have all acknowledged that that they are monitoring the situation and potential for the outbreak to affect supply chains.

BMS scores first oesophageal cancer nod for Opdivo in Japan

BMS scores first oesophageal cancer nod for Opdivo in Japan That includes Keytruda, Roche’s Tecentriq (atezolizumab), AstraZeneca’s Imfinzi (druvalumab) and Sanofi’s latecomer Libtayo (cemiplimab).

GSK pays $50m upfront to tap Immatics’ cell therapy platform

GSK pays $50m upfront to tap Immatics’ cell therapy platform Deal focuses on T cell receptor therapies

Targacept picks Solvay's Stephen Hill to fill vacant CEO post

Targacept picks Solvay's Stephen Hill to fill vacant CEO post Prior to that, he served at US biotech ArQule and Roche, where he held several leadership positions including global head of clinical development.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics